View of COMPARATIVE RENAL BIOMARKER TRAJECTORIES AND MOLECULAR–GENETIC IMPLICATIONS OF SGLT-2 VERSUS DPP-4 INHIBITOR THERAPY IN TYPE 2 DIABETES MELLITUS: A 12-MONTH PROSPECTIVE OBSERVATIONAL STUDY

Return to Article Details COMPARATIVE RENAL BIOMARKER TRAJECTORIES AND MOLECULAR–GENETIC IMPLICATIONS OF SGLT-2 VERSUS DPP-4 INHIBITOR THERAPY IN TYPE 2 DIABETES MELLITUS: A 12-MONTH PROSPECTIVE OBSERVATIONAL STUDY Download Download PDF